
Factbooks
An introduction for investors and analysts to DSM, our Nutrition, Materials and Innovation Center clusters and our businesses.
Our Purpose-led, Performance-driven strategy is our commitment to the world. We know we can create financial opportunity and do good for the planet. We have a responsibility to demonstrate how we can create value for our stakeholders, improve people's lives today and for generations to come whilst making a difference to the environment we live in.
Being a purpose-led company means we place the same emphasis on delivering on our people and planet responsibilities and ambitions as we do on meeting our financial targets. Sustainability is core to our purpose and key to driving our future growth. By delivering science-based solutions we aim to create brighter lives for people today and for generations to come.
GHG absolute reduction (vs. 2016)
Energy efficiency improvement year-on-year
Purchased renewable electricity
Employee engagement favorable score
Female
executives
Under-represented nationalities
Safety Frequency Recordable Index
Brighter Living
Solutions
Strategy 2018 outpaced market growth and delivered double digit EBITDA growth per annum.
Human Nutrition CAGR
Animal Nutrition CAGR
Materials CAGR
High single digit
High double digit bps
Human Nutrition CAGR
Animal Nutrition CAGR
Materials CAGR
CAGR of underlying business
Average Base Percentage Points
We aim to continue strengthening our sustainability leadership with People and Planet targets we must achieve during the Strategy 2021 period and beyond.
GHG absolute reduction (vs. 2016) by 2030
Energy efficiency improvement till 2030
Purchased renewable electricity by 2030
Employee engagement favorable score by 2021
Female
executives by 2020
Under-represented nationalities by 2020
Safety Frequency Recordable Index by 2021
Brighter Living
Solutions by 2021
Develop and introduce new innovative sustainable solutions with focus on our Nutrition & Health, Climate & Energy and Resources & Circularity domains.
We use our key competences to address the UN Sustainable Development Goals. These provide growth opportunities in Nutrition & Health, Climate & Energy and Resources & Circularity and expand beyond the ~2.5 billion people we currently reach.
The current strategy has two key financial targets:
Underpinned by group targets:
Eubotics / Gut Health
(feed / food)
i-Health
(B2C nutrients)
Plant-Based Proteins
(CanolaPRO®)
Bio-Agri
(fungicides/pesticides)
New Biomedical Products
(tissue repair/ophtalmology)
Solar
(coatings/backsheets)
Enzymes/Yeast
(1.5 - 2G ethanol)
Actamax
(biomed adhesion barrier)
New Functional Materials
(5G)
Apparel
(Dyneema® textile applications)
ForTii®
(High-Performance Polymer)
Expected Sales/Adjusted EBITDA in 2021 and 2025 of large projects: ~€350m/€100m rising to ~€1bn/€0.4bn
Total innovation sales (at higher margins) remain at 20% of sales
DSM maintains a highly disciplined financial approach to drive optimum value for stakeholders.
Focus on nutrition
Stable, preferably rising
Expected average pay-out of 40/50% of adjusted (underlying) earnings
Prudent and disciplined approach
Focus on nutrition
To be considered in the absence of value-creating M&A
An introduction for investors and analysts to DSM, our Nutrition, Materials and Innovation Center clusters and our businesses.
Instant overview of the financial results, presentations, updates & AGMs and all DSM's financial and regulatory press releases from the last decade.
DSM's ordinary shares, share performance, share listings, share structure, cumulative preference shares and shareholder base.